Recent Transactions

20-Apr-17
Pending
$4.3 billion
canada.gif
Target: 

Brookfield Canada Office Properties

U.S.A. flag
Acquiror: 
Brookfield Property Partners L.P.

Advised the Special Committee of Brookfield Canada Office Properties, Canada’s pre-eminent office real estate investment trust, on its go private transaction with Brookfield Property Partners L.P.

03-Apr-17
Pending
$400 million
U.S.A. flag
Target: 

Cheetahmail

U.S.A. flag
Acquiror: 
Vector Capital

Advising Vector Capital on the acquisition of Cheetahmail from Experian plc

03-Apr-17
$205 million
australia.gif
Target: 

Inenco Group Pty Ltd

U.S.A. flag
Acquiror: 
Genuine Parts Company

Advised Inenco Group Pty Ltd, one of Australasia’s leading industrial distributors, on the partial sale to Genuine Parts Company, a global distributor of automotive and industrial products

22-Feb-17
$533 million
australia.gif
Target: 

Lion’s stake in Warrnambool Cheese and Butter Factory Company

canada.gif
Acquiror: 
Saputo Inc.

Advised Lion (an Australian subsidiary of Kirin), on the sale of its strategic stake in Warrnambool Cheese and Butter Factory to Canadian-based Saputo, under its all cash takeover offer

10-Feb-17
Pending
$2.0 billion
U.S.A. flag
Target: 

Immunomedics, Inc. lead product candidate, IMMU-132

U.S.A. flag
Acquiror: 
Seattle Genetics

Advising Immunomedics, Inc. on the exclusive global licensing agreement with Seattle Genetics for the rights to develop, manufacture and commercialize sacituzumab govitecan (“IMMU-132”), an antibody-drug conjugate (ADC) targeted to TROP-2, which is expressed in several solid tumors, including cancers of the breast, lung and bladder

27-Jan-17
Pending
$4.6 billion
uk.gif
Target: 

Booker Group plc

uk.gif
Acquiror: 
Tesco plc

Advising Tesco plc, the UK’s leading retailer, on its merger with Booker Group plc, the UK’s leading food wholesaler, to create the UK’s leading food business

03-Jan-17
Pending
$536 million
uk_france.gif
Target: 

LCH.Clearnet SA

france.gif
Acquiror: 
Euronext N.V.

Advising LCH.Clearnet Group Limited, a leading multi-asset class European clearing house, on the sale of LCH.Clearnet SA, its French-regulated operating subsidiary, to Euronext N.V.

22-Dec-16
$290 million
Chile Flag
Target: 

Subsidiaries and affiliates of Empresas Indumotora S.A.

uk.gif
Acquiror: 
Inchcape PLC

Advised Inchcape PLC, a global leader in automotive retail and distribution, on the acquisition of a multi-country scale distribution business in Chile, Peru, Colombia, and Argentina for $290m (approximately £234m)

12-Dec-16
$NA
U.S.A. flag
Target: 

Gradifi, Inc.

U.S.A. flag
Acquiror: 
First Republic Bank

Advised First Republic Bank, a provider of private banking, private business banking and private wealth management services, on the acquisition of Gradifi, a Boston-based technology and service platform used by employers to make direct contributions to employees’ student loans

06-Dec-16
$1.8 billion
U.K., German flags
Target: 

Host Europe Group

U.S.A. flag
Acquiror: 
GoDaddy

Advising GoDaddy, the largest domain name registrar worldwide and a leading web hosting provider, on its acquisition of Host Europe Group, the largest privately owned web services provider in Europe

01-Dec-16
Pending
$116 million
brazil.gif
Target: 

Rico

brazil.gif
Acquiror: 
XP Investimentos

Advised the founding shareholders of Rico, a leading independent online investment platform in Brazil, on its 100% sale to XP Investimentos, a Brazilian investment firm

23-Nov-16
Pending
$NA
israel.gif
Target: 

Portfolio of generic marketed products in France from Teva Pharmaceutical Industries Ltd.

france.gif
Acquiror: 
Arrow Generiques SAS

Advising Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on the divestment of a portfolio of generic marketed products in France to Arrow Generiques SAS (a subsidiary of Aurobindo Pharma Limited).

14-Nov-16
$748 million
U.S.A. flag
Target: 

Peacock Foods

uk.gif
Acquiror: 
Greencore Group plc

Advising Greencore Group plc, a leading international manufacturer of convenience foods based in Ireland, on the proposed acquisition of Peacock Foods, a manufacturing partner for consumer packaged goods companies in the US.

14-Nov-16
$NA
australia.gif
Target: 

Lion’s Australian Premium Wine Business – Fine Wine Partners

australia.gif
Acquiror: 
Accolade Wines

Advised Lion, a leading Australasian food and beverage company wholly owned by Japanese conglomerate Kirin, on the sale of its Australian wine business Fine Wine Partners to Accolade Wines, a portfolio company of CHAMP Private Equity

03-Nov-16
$3.3 billion
U.S.A. flag
Target: 

Metaldyne Performance Group, Inc.

U.S.A. flag
Acquiror: 
American Axle & Manufacturing Holdings, Inc.

Advising American Axle & Manufacturing Holdings, Inc., a leading manufacturer of driveline and drivetrain systems and related components and metal-formed products, on the acquisition of Metaldyne Performance Group, Inc., a provider of highly-engineered lightweight components for use in powertrain and suspension applications for the global light, commercial and industrial vehicle markets

03-Nov-16
$NA
switzerland.gif
Target: 

Fragrance Resources Group

U.S.A. flag
Acquiror: 
International Flavors & Fragrances Inc.

Advising IFF, one of the world’s largest flavors and fragrances businesses, on the acquisition of Fragrance Resources Group, a family-owned fragrance company headquartered in Switzerland

17-Oct-16
$1.4 billion
U.S.A. flag
Target: 

Save-A-Lot

canada.gif
Acquiror: 
Affiliate of Onex Corporation

Advising SUPERVALU, Inc., one of the largest grocery wholesalers and retailers in the U.S., on the sale of its Save-A-Lot business, a leading hard-discount grocery retailer in the U.S., to an affiliate of Onex Corporation 

05-Oct-16
$775 million
uk-ireland_35558.gif
Target: 

Assets and operations of Actavis Generics in the UK and Ireland from Teva Pharmaceutical Industries Ltd.

india.gif
Acquiror: 
Accord Healthcare Ltd.

Advising Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on its sale of assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited) for £603m (c.$775m) 

05-Oct-16
Pending
$NA
israel.gif
Target: 

Portfolio of 14 Outlicensing generic products in the EEA from Teva Pharmaceutical Industries Ltd.

india.gif
Acquiror: 
Accord Healthcare Ltd.

Advising Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on the divestment of a portfolio of 14 Outlicensing pharmaceutical products in the EEA to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited).

07-Sep-16
Pending
$NA
U.S.A. flag
Target: 

TEGNA, Inc.

flag not available

Advising TEGNA, Inc., a major broadcasting and digital marketing services company, on the spin-off of Cars.com and the creation of two independent publicly traded companies: one focused on television broadcasting and one focused on the online automotive marketplace.

18-Aug-16
$3.2 billion
switzerland.gif
Target: 

Valves & Controls Business of Pentair

U.S.A. flag
Acquiror: 
Emerson

Advising Emerson, a diversified global technology and industrial company, on the acquisition of the Valves & Controls business of Pentair

08-Aug-16
$1.5 billion
canada.gif
Target: 

Whistler Blackcomb Holdings Inc.

U.S.A. flag
Acquiror: 
Vail Resorts, Inc.

Advised Whistler Blackcomb Holdings Inc., a 75% owner and operator of the largest and most visited mountain resort in North America, on its sale to Vail Resorts, Inc.

08-Aug-16
$87 million
U.S.A. flag
Target: 

Aquasana, Inc.

U.S.A. flag
Acquiror: 
A. O. Smith Corporation

Advised A. O. Smith Corporation, a leading manufacturer of residential and commercial water heaters and boilers, on the acquisition of Aquasana, a premium water treatment company, from L Catterton

28-Jul-16
$80 million
U.S.A. flag
Target: 

BioD, LLC

U.S.A. flag
Acquiror: 
Derma Sciences, Inc.

Advised Derma Sciences, Inc., a tissue regeneration company focused on advanced wound and burn care, on the acquisition of a proprietary regenerative medicine products company BioD, LLC and a concurrent private placement.

28-Jun-16
$NA
israel.gif
Target: 

U.S. rights to an authorized generic version of Adderall XR

U.S.A. flag
Acquiror: 
Prasco Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights  to an authorized generic version of Adderall XR

Pages

show all